JP2007524710A5 - - Google Patents

Download PDF

Info

Publication number
JP2007524710A5
JP2007524710A5 JP2007500295A JP2007500295A JP2007524710A5 JP 2007524710 A5 JP2007524710 A5 JP 2007524710A5 JP 2007500295 A JP2007500295 A JP 2007500295A JP 2007500295 A JP2007500295 A JP 2007500295A JP 2007524710 A5 JP2007524710 A5 JP 2007524710A5
Authority
JP
Japan
Prior art keywords
quinolin
dihydro
dimethyl
phenyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007500295A
Other languages
English (en)
Japanese (ja)
Other versions
JP4712027B2 (ja
JP2007524710A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2005/000717 external-priority patent/WO2005082856A2/en
Publication of JP2007524710A publication Critical patent/JP2007524710A/ja
Publication of JP2007524710A5 publication Critical patent/JP2007524710A5/ja
Application granted granted Critical
Publication of JP4712027B2 publication Critical patent/JP4712027B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007500295A 2004-02-27 2005-02-25 テトラヒドロキノリノン類及び代謝型グルタミン酸受容体のアンタゴニストとしてのその使用 Expired - Fee Related JP4712027B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54878804P 2004-02-27 2004-02-27
US60/548,788 2004-02-27
PCT/GB2005/000717 WO2005082856A2 (en) 2004-02-27 2005-02-25 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors

Publications (3)

Publication Number Publication Date
JP2007524710A JP2007524710A (ja) 2007-08-30
JP2007524710A5 true JP2007524710A5 (cg-RX-API-DMAC10.html) 2010-08-26
JP4712027B2 JP4712027B2 (ja) 2011-06-29

Family

ID=34911013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007500295A Expired - Fee Related JP4712027B2 (ja) 2004-02-27 2005-02-25 テトラヒドロキノリノン類及び代謝型グルタミン酸受容体のアンタゴニストとしてのその使用

Country Status (23)

Country Link
US (1) US7598384B2 (cg-RX-API-DMAC10.html)
EP (1) EP1723116B1 (cg-RX-API-DMAC10.html)
JP (1) JP4712027B2 (cg-RX-API-DMAC10.html)
KR (1) KR100846347B1 (cg-RX-API-DMAC10.html)
CN (1) CN1922146A (cg-RX-API-DMAC10.html)
AR (1) AR049006A1 (cg-RX-API-DMAC10.html)
AT (1) ATE409182T1 (cg-RX-API-DMAC10.html)
AU (1) AU2005217199B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0508225A (cg-RX-API-DMAC10.html)
CA (1) CA2556653C (cg-RX-API-DMAC10.html)
DE (1) DE602005009929D1 (cg-RX-API-DMAC10.html)
DK (1) DK1723116T3 (cg-RX-API-DMAC10.html)
EA (1) EA010656B1 (cg-RX-API-DMAC10.html)
ES (1) ES2315853T3 (cg-RX-API-DMAC10.html)
IL (1) IL177524A (cg-RX-API-DMAC10.html)
PL (1) PL1723116T3 (cg-RX-API-DMAC10.html)
PT (1) PT1723116E (cg-RX-API-DMAC10.html)
SI (1) SI1723116T1 (cg-RX-API-DMAC10.html)
TW (1) TWI301760B (cg-RX-API-DMAC10.html)
UA (1) UA83549C2 (cg-RX-API-DMAC10.html)
UY (1) UY28775A1 (cg-RX-API-DMAC10.html)
WO (1) WO2005082856A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200606686B (cg-RX-API-DMAC10.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007023242A1 (en) * 2005-08-24 2007-03-01 Merz Pharma Gmbh & Co. Kgaa Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
EP1943247A1 (en) * 2005-08-25 2008-07-16 Merz Pharma GmbH & Co.KGaA Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006303037A1 (en) * 2005-10-21 2007-04-26 Merz Pharma Gmbh & Co Kgaa Chromenones and their use as modulators of metabotropic glutamate receptors
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
AR057218A1 (es) * 2005-12-15 2007-11-21 Astra Ab Compuestos de oxazolidinona y su uso como pontenciadores del receptor metabotropico de glutamato
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
SG173409A1 (en) * 2006-11-24 2011-08-29 Ac Immune Sa N-(methyl)-1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimers
MX2011004680A (es) * 2008-11-06 2011-05-25 Astrazeneca Ab Moduladores de beta amiloide.
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
UY32622A (es) * 2009-05-12 2010-12-31 Astrazeneca Ab Nuevos compuestos para el tratamiento de patologías relacionadas con ab(beta)
EP2311823A1 (en) 2009-10-15 2011-04-20 AC Immune S.A. 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
EP2513117B1 (en) 2009-12-18 2013-08-28 Janssen Pharmaceutica, N.V. Bicyclic thiazoles as allosteric modulators of mglur5 receptors
AU2010332819B2 (en) 2009-12-18 2014-02-27 Janssen Pharmaceutica Nv Bicyclic thiazoles as allosteric modulators of mGluR5 receptors
GB0922589D0 (en) * 2009-12-23 2010-02-10 Almac Discovery Ltd Pharmaceutical compounds
WO2012052451A1 (en) 2010-10-18 2012-04-26 Merz Pharma Gmbh & Co. Kgaa Metabotropic glutamate receptor modulators
EP2640703A1 (en) * 2010-11-16 2013-09-25 GE Healthcare UK Limited Heterocyclic compounds as imaging probes of tau pathology
WO2012139876A1 (en) 2011-04-14 2012-10-18 Merz Pharma Gmbh & Co. Kgaa Enteric formulations of metabotropic glutamate receptor modulators
JPWO2014034898A1 (ja) * 2012-08-30 2016-08-08 日本新薬株式会社 ピリジン誘導体及び医薬
US10059671B2 (en) 2013-02-04 2018-08-28 Prexton Therapeutics Sa Positive allosteric modulators of mGluR3
CN104513200B (zh) * 2013-09-26 2017-05-03 江苏苏中药业集团股份有限公司 取代丁烯酰胺的马来酸盐及其晶型
TWI713455B (zh) 2014-06-25 2020-12-21 美商伊凡克特治療公司 MnK抑制劑及其相關方法
KR102702236B1 (ko) 2015-05-15 2024-09-04 오리진 온콜로지 리미티드 Ror 감마 조절제로서의 치환된 테트라하이드로퀴놀리논 화합물
SG11201803242TA (en) * 2015-10-29 2018-05-30 Effector Therapeutics Inc Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of mnk1 and mnk2
WO2017087808A1 (en) 2015-11-20 2017-05-26 Effector Therapeutics, Inc. Heterocyclic compounds that inhibit the kinase activity of mnk useful for treating various cancers
US20200123127A1 (en) * 2016-04-25 2020-04-23 Everon Biosciences, Inc. Removal of senescence-associated macrophages
DK3582776T3 (da) 2017-02-14 2024-01-08 Effector Therapeutics Inc Piperidinsubstituerede mnk-hæmmere og dertil relaterede fremgangsmåder
EP3870178A4 (en) 2018-10-24 2022-08-03 Effector Therapeutics Inc. Crystalline forms of mnk inhibitors
GB2600384A (en) 2020-09-30 2022-05-04 Vaderis Therapeutics Ag Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia
US20250241905A1 (en) * 2022-06-23 2025-07-31 The Cleveland Clinic Foundation 3-beta-hsd1 inhibitors and compositions and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3501479A (en) * 1967-05-19 1970-03-17 American Cyanamid Co Dihydroquinolines and substituted dihydroquinolines and method of preparing the same
DE2001572A1 (de) 1970-01-15 1971-07-22 Agfa Gevaert Ag Spektral sensibilisiertes lichtempfindliches Material
DE2449030A1 (de) 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
WO1988002251A1 (en) 1986-09-26 1988-04-07 Ici Australia Operations Proprietary Limited Sunscreen compositions and compounds for use therein
US5110815A (en) * 1990-12-03 1992-05-05 Hoechst-Roussel Pharmaceuticals Inc. 5-amino-5,6,7,8-tetrahydroquinolines and related compounds and pharmaceutical use
US5216164A (en) * 1990-12-03 1993-06-01 Hoechst-Roussel Pharmaceuticals Incorporated 5-amino-5,6,7,8-tetrahydroquinolines and related compounds
AU4481899A (en) * 1998-02-20 1999-09-06 Takeda Chemical Industries Ltd. Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof
GB0003632D0 (en) 2000-02-16 2000-04-05 Univ Hong Kong Science & Techn Dimeric compounds
CN1703403A (zh) 2000-10-02 2005-11-30 詹森药业有限公司 趋代谢的谷氨酸盐受体拮抗剂
NZ535438A (en) 2002-03-29 2006-08-31 Janssen Pharmaceutica Nv Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands

Similar Documents

Publication Publication Date Title
CA2556653A1 (en) Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
US12378266B2 (en) Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
JP2025004090A (ja) 統合失調症を治療するための2-((1-(2(4-フルオロフェニル)-2-オキソエチル)ピペリジン-4-イル)メチル)イソインドリン-1-オン
JP2005510473A5 (cg-RX-API-DMAC10.html)
TWI720272B (zh) 雜芳基苯氧基苯甲醯胺kappa類鴉片配體
JP2006206609A5 (cg-RX-API-DMAC10.html)
JP5719852B2 (ja) 7−クロロ−キノリン−4−アミン化合物、ならびにアミロイド斑の形成を含み、及び/又はappの代謝機能障害が生じる疾患の予防又は治療のためのそれらの使用
AU2005238296A1 (en) Substituted morpholine compounds for the treatment of central nervous system disorders
JP2013542267A5 (cg-RX-API-DMAC10.html)
JP6615864B2 (ja) 6,7−ジヒドロピラゾロ[1,5−a]ピラジン−4(5H)−オン化合物およびMGLUR2受容体の負のアロステリック調節因子としてのそれらの使用
RU2013125338A (ru) Производные триазола в качестве лигандов рецепторов гамк
JP3521214B2 (ja) 4,5−ジヒドロイソオキサゾリルアルキルピペラジン誘導体とその製造方法並びにドーパミン拮抗剤
JP2019511466A5 (cg-RX-API-DMAC10.html)
WO2010012121A1 (zh) 芳烷基哌啶(嗪)衍生物及其在治疗精神分裂症中的应用
JP2008543782A (ja) 5−ht1a受容体のピペラジン−ピペリジンアンタゴニストおよびアゴニスト
JP2023528281A5 (cg-RX-API-DMAC10.html)
KR20140003497A (ko) 바이사이클릭 벤젠 유도체로 치환된 신규 항진균성 5,6-디하이드로-4H-피롤로[1,2-a][1,4]벤조디아제핀 및 6H-피롤로[1,2-a][1,4]벤조디아제핀
JP2023503465A5 (cg-RX-API-DMAC10.html)
CZ2003140A3 (cs) Nová forma (R)-N-[5-methyl-8-(4-methylpiperazin-l-yl)-1,2,3,4-tetrahydro-2-naftyl]-4-morfolinobenzamidu
CA2552914A1 (en) Diaza-spiropiperidine derivatives
JP6025886B2 (ja) 慢性疼痛治療剤
RU2016128365A (ru) 5-арил-1-имино-1-оксо-[1,2,4]тиадиазины
US20110207745A1 (en) Solid forms of 4--n,n-diethylbenzamide, compositions thereof, and uses therewith
US20130131079A1 (en) Flufenoxine derivatives for the treatment and prevention of amyloid pathologies
CN1386504A (zh) 用于抑郁症和焦虑的联合治疗